Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Evofem Biosciences, Inc. (EVFM)

0.18905   -0.015 (-7.33%) 09-24 14:46
Open: 0.22 Pre. Close: 0.204
High: 0.229 Low: 0.1875
Volume: 3,398,917 Market Cap: 16(M)
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.23 - 0.23 0.23 - 0.23
Low: 0.18 - 0.19 0.19 - 0.19
Close: 0.19 - 0.19 0.19 - 0.19

Technical analysis

as of: 2022-09-23 4:23:54 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 0.39     One year: 0.52
Support: Support1: 0.15    Support2: 0.13
Resistance: Resistance1: 0.33    Resistance2: 0.44
Pivot: 0.27
Moving Average: MA(5): 0.19     MA(20): 0.29
MA(100): 0.62     MA(250): 4.25
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 15.1     %D(3): 10.8
RSI: RSI(14): 26.7
52-week: High: 12.3  Low: 0.15
Average Vol(K): 3-Month: 18,149 (K)  10-Days: 2,567 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ EVFM ] has closed above bottom band by 12.7%. Bollinger Bands are 74.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 21 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 23 Sep 2022
Evofem Biosciences (EVFM) Announces Issuance of U.S. Patent Covering Phexxi Composition of Matter -

Fri, 16 Sep 2022
EVFM stock on watch as company restructures debt (OTCMKTS:EVFM) - Seeking Alpha

Mon, 12 Sep 2022
Evofem (EVFM) And The Phexxi Launch - Seeking Alpha

Wed, 17 Aug 2022
Evofem Biosciences Inc (NASDAQ: EVFM) Reports Q2 2022 Financial Results With Phexxi Sales of $6 million - BP Journal

Wed, 10 Aug 2022
Is Evofem Biosciences Inc (EVFM) a Good Choice in Biotechnology Wednesday? - InvestorsObserver

Thu, 04 Aug 2022
Evofem Biosciences reports Q2 results (OTCMKTS:EVFM) - Seeking Alpha

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Outperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Underperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 85 (M)
Shares Float 85 (M)
% Held by Insiders 0.4 (%)
% Held by Institutions 9.6 (%)
Shares Short 8,680 (K)
Shares Short P.Month 17,820 (K)

Stock Financials

EPS -19.01
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -2.74
Profit Margin (%) 0
Operating Margin (%) -861.7
Return on Assets (ttm) -103.4
Return on Equity (ttm) 0
Qtrly Rev. Growth 224.8
Gross Profit (p.s.) 0.04
Sales Per Share 0.18
EBITDA (p.s.) -1.56
Qtrly Earnings Growth 0
Operating Cash Flow -106 (M)
Levered Free Cash Flow 68 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value -0.07
Price to Sales 1.03
Price to Cash Flow -0.16

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2018-01-17
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.